Journal article icon

Journal article

Deep learning for detecting tumour infiltrating lymphocytes in testicular germ cell tumors

Abstract:
Aims To evaluate if a deep learning algorithm can be trained to identify tumour-infiltrating lymphocytes (TILs) in tissue samples of testicular germ cell tumours and to assess whether the TIL counts correlate with relapse status of the patient.

Methods TILs were manually annotated in 259 tumour regions from 28 whole-slide images (WSIs) of H&E-stained; tissue samples. A deep learning algorithm was trained on half of the regions and tested on the other half. The algorithm was further applied to larger areas of tumour WSIs from 89 patients and correlated with clinicopathological data.

Results A correlation coefficient of 0.89 was achieved when comparing the algorithm with the manual TIL count in the test set of images in which TILs were present (n=47). In the WSI regions from the 89 patient samples, the median TIL density was 1009/mm2. In seminomas, none of the relapsed patients belonged to the highest TIL density tertile (>2011/mm2). TIL quantifications performed visually by three pathologists on the same tumours were not significantly associated with outcome. The average interobserver agreement between the pathologists when assigning a patient into TIL tertiles was 0.32 (Kappa test) compared with 0.35 between the algorithm and the experts, respectively. A higher TIL density was associated with a lower clinical tumour stage, seminoma histology and lack of lymphovascular invasion.

Conclusions Deep learning–based image analysis can be used for detecting TILs in testicular germ cell cancer more objectively and it has potential for use as a prognostic marker for disease relapse.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1136/jclinpath-2018-205328

Authors

More by this author
Institution:
University of Oxford
Division:
NDM
Department:
Wellcome Trust Centre for Human Genetics
Oxford college:
St Edmund Hall
Role:
Author
More by this author
Institution:
University of Oxford
Division:
RDM
Department:
RDM Clinical Laboratory Sciences
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Medical School
Role:
Author


More from this funder
Funding agency for:
Verrill, C
Grant:
Biomedical Research Centre


Publisher:
BMJ Publishing Group
Journal:
Journal of Clinical Pathology More from this journal
Volume:
72
Issue:
2
Publication date:
2018-12-05
Acceptance date:
2018-11-03
DOI:
EISSN:
1472-4146
ISSN:
0021-9746


Pubs id:
pubs:944874
UUID:
uuid:7dd6ad79-25a4-4f64-801f-d4791b43386f
Local pid:
pubs:944874
Source identifiers:
944874
Deposit date:
2018-11-21
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP